Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MBRX

Moleculin Biotech, Inc.

CIK 0001659617 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.59
↑ 0.00 (0.41%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$4.21M
P/E Ratio
-0.11
EPS
-28.42
Dividend Yield
Not covered
52W Position
6%
Beta
0.99

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
0.36
P/S
Not covered
EV/Revenue
Not covered
ROE
-344.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.16$7.98

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$33.56M
Total Assets
$22.13M
Free Cash Flow
-$22.73M

Recent news